Einstein Stenton Ave is categorized under Medical Centers in Philadelphia, PA .
Einstein Stenton Ave was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Elizabeth Olesniewicz, Office Manager at the company’s single location by writing to 1602 East Wadsworth Avenue, Philadelphia, Pennsylvania PA 19150 or by phoning (215) 248-2313. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Einstein Stenton Ave |
Contact Person: | Elizabeth Olesniewicz, Office Manager |
Address: | 1602 East Wadsworth Avenue, Philadelphia, Pennsylvania 19150 |
Phone Number: | (215) 248-2313 |
Website Address: | einstein.edu |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Centers |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Einstein Stenton Ave was started in 0 to provide professional Medical Centers under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Elizabeth Olesniewicz, Office Manager for inquiries that concern Einstein Stenton Ave by calling the company number (215) 248-2313, as your correspondence is most welcome. Additionally, the physical location of the single location of Einstein Stenton Ave can be found at the coordinates 40.08084,-75.17212 as well as the street address 1602 East Wadsworth Avenue in Philadelphia, Pennsylvania 19150.
For its online presence, you may visit Einstein Stenton Ave’s website at einstein.edu and engage with its social media outlets through on Twitter and on Facebook.